ARTICLE | Clinical News

Qutenza capsaicin regulatory update

October 12, 2015 7:00 AM UTC

The European Commission approved a label extension for Qutenza capsaicin 8% patch from Astellas to treat peripheral neuropathic pain alone or in combination with other pain drugs to include adult diabetics. The dermal patch containing capsaicin is approved in the EU in non-diabetic adults. ...